These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 16222628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Goff DC, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL, Simons-Morton DG, ACCORD Study Group.
    Am J Cardiol; 2007 Jun 18; 99(12A):4i-20i. PubMed ID: 17599424
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G.
    Orv Hetil; 1999 Jul 11; 140(28):1563-72. PubMed ID: 10443132
    [Abstract] [Full Text] [Related]

  • 8. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z, Werstuck GH, Gerstein HC.
    Rev Cardiovasc Med; 2007 Jul 11; 8(3):145-53. PubMed ID: 17938614
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Management of cardiovascular risk in diabetic patients: evolution or revolution?
    Ceriello A, Sechi LA.
    Diabetes Nutr Metab; 2002 Apr 11; 15(2):121-7. PubMed ID: 12059094
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS, Pencina MJ, D'Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):264-70. PubMed ID: 18206734
    [Abstract] [Full Text] [Related]

  • 15. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun 22; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
    Yosefy C.
    Acta Diabetol; 2003 Dec 22; 40 Suppl 2():S380-8. PubMed ID: 14704873
    [Abstract] [Full Text] [Related]

  • 19. Reassessment of cardiovascular risk in diabetes.
    Jaffe JR, Nag SS, Landsman PB, Alexander CM.
    Curr Opin Lipidol; 2006 Dec 22; 17(6):644-52. PubMed ID: 17095909
    [Abstract] [Full Text] [Related]

  • 20. Fasting glucose and cardiovascular risk factors in an urban population.
    Gupta R, Sarna M, Thanvi J, Sharma V, Gupta VP.
    J Assoc Physicians India; 2007 Oct 22; 55():705-9. PubMed ID: 18173023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.